Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 2Tuberculosis, Pulmonary 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pneumonia 1Motor Activity 1Lung Injury 1Hypoxia 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × Thoracotomy × Clear all
NCT03786003 2023-07-21

ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)

Fudan University

Phase NA Recruiting
1,086 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02360761 2016-09-20

STEPS

Peking University People's Hospital

Phase 3 Unknown
339 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡